HOMEVULNERABILITIESCVE-2018-14787
HIGH

CVE-2018-14787

CWE-269Published: August 22, 2018· Updated: Jun 17, 2026

7.8
CVSS v3.1

Official Description

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

NVD Source

Technical Analysis

CVE-2018-14787 requires local access, meaning attackers must already have a foothold on the target system.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 7.8.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorLocal
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

philips2 product(s)
intellispace cardiovascularxcelera
Source: NVD CPE · 2 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

ADVISORYhttps://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
ADVISORYhttps://www.usa.philips.com/healthcare/about/customer-support/product-security
ADVISORYhttps://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
ADVISORYhttps://www.usa.philips.com/healthcare/about/customer-support/product-security

All References (4)

→
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party Advisory · US Government Resource
→
https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
→
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party Advisory · US Government Resource
→
https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory

Quick Facts

CVE IDCVE-2018-14787
CVSS Score7.8 / 10
SeverityHIGH
WeaknessCWE-269
CISA KEVNo
Affected1 vendor(s)
PublishedAug 22, 2018

Related CVEs (CWE-269)

CVE-2026-31852
10.0
CVE-2025-0505
10.0
CVE-2021-1388
10.0
CVE-2020-27655
10.0
CVE-2018-4310
10.0
CVE-2022-24783
10.0

Recommended Actions

  • →Apply vendor patches immediately
  • →Monitor CVE-2018-14787 in threat intel feeds
  • →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.
← All Vulnerabilities·Search for CVE-2018-14787·NVD